Stocktoria
IRADIMED CORP IRMD
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2014-07-16
IRADIMED CORP statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 76.7% | 76.9% | 76.5% | 77.4% | 76.6% |
| Operating margin | 31.2% | 30.0% | 30.6% | 29.3% | 23.5% |
| Net margin | 26.8% | 26.3% | 26.2% | 24.1% | 22.3% |
| FCF margin | 20.5% | 24.1% | 9.2% | 17.3% | 25.8% |
| Return on assets | 20.7% | 19.6% | 18.7% | 15.0% | 11.3% |
| Return on equity | 23.8% | 22.2% | 24.1% | 17.4% | 12.9% |
| Current ratio | 7.98 | 8.84 | 4.65 | 9.06 | 11.18 |
| Revenue growth | 14.4% | 11.7% | 23.0% | 27.5% | 31.8% |
Source: SEC EDGAR filings · CIK 0001325618 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.